Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CYTR NASDAQ:FLN NASDAQ:FTXH NASDAQ:GXTG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCYTRLadRx$0.09$0.05▼$0.86$4.14MN/A99,706 shs4,000 shsFLNFirst Trust Latin America AlphaDEX Fund$18.95+0.1%$19.42$15.03▼$21.39$15.16M1.098,691 shs11,178 shsFTXHFirst Trust Nasdaq Pharmaceuticals ETF$26.10+1.3%$26.06$23.28▼$29.72$14.36M0.78,024 shs789 shsGXTGGlobal X Thematic Growth ETF$26.08-0.6%$25.44$21.41▼$26.12$12.26M1.234,021 shs383 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCYTRLadRx0.00%0.00%0.00%0.00%0.00%FLNFirst Trust Latin America AlphaDEX Fund+0.11%-0.73%-5.86%-0.05%+5.69%FTXHFirst Trust Nasdaq Pharmaceuticals ETF+1.41%-3.60%-0.75%+1.28%-8.57%GXTGGlobal X Thematic Growth ETF0.00%-1.10%+1.70%+11.08%+11.15%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCYTRLadRxN/AN/AN/AN/AN/AN/AN/AN/AFLNFirst Trust Latin America AlphaDEX FundN/AN/AN/AN/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AN/AN/AGXTGGlobal X Thematic Growth ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCYTRLadRx 0.00N/AN/AN/AFLNFirst Trust Latin America AlphaDEX Fund 0.00N/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETF 2.53Moderate Buy$26.10N/AGXTGGlobal X Thematic Growth ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCYTRLadRxN/AN/AN/AN/AN/AN/AFLNFirst Trust Latin America AlphaDEX FundN/AN/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AGXTGGlobal X Thematic Growth ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCYTRLadRxN/AN/A0.00N/AN/AN/AN/AN/AN/AFLNFirst Trust Latin America AlphaDEX FundN/AN/A9.93∞N/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/A14.51∞N/AN/AN/AN/AN/AGXTGGlobal X Thematic Growth ETFN/AN/A26.08∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCYTRLadRxN/AN/AN/AN/AN/AFLNFirst Trust Latin America AlphaDEX Fund$0.753.96%N/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETF$0.441.69%N/AN/AN/AGXTGGlobal X Thematic Growth ETF$0.250.96%N/AN/AN/ALatest CYTR, FTXH, FLN, and GXTG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/25/2025FLNFirst Trust Latin America AlphaDEX FundQuarterly$0.27095.55%6/26/20256/26/20256/30/20256/25/2025FTXHFirst Trust Nasdaq Pharmaceuticals ETFQuarterly$0.08921.39%6/26/20256/26/20256/30/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCYTRLadRxN/AFLNFirst Trust Latin America AlphaDEX FundN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AGXTGGlobal X Thematic Growth ETFN/AInsider OwnershipCompanyInsider OwnershipCYTRLadRxN/AFLNFirst Trust Latin America AlphaDEX FundN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AGXTGGlobal X Thematic Growth ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCYTRLadRxN/A45.04 millionN/ANot OptionableFLNFirst Trust Latin America AlphaDEX Fund147,000800,000N/ANot OptionableFTXHFirst Trust Nasdaq Pharmaceuticals ETF147,000550,000N/AOptionableGXTGGlobal X Thematic Growth ETF147,000470,000N/AOptionableCYTR, FTXH, FLN, and GXTG HeadlinesRecent News About These CompaniesIntroducing The Global X PureCap Suite: Exploring Innovation Beyond Traditional Sector InvestingJuly 24, 2025 | seekingalpha.comHow To Trade (GXTG)February 6, 2025 | news.stocktradersdaily.comN(GXTG) Trading ReportJanuary 26, 2025 | news.stocktradersdaily.comN(GXTG) Trading SignalsJanuary 16, 2025 | news.stocktradersdaily.comN(GXTG) Pivots Trading Plans and Risk ControlsJanuary 5, 2025 | news.stocktradersdaily.comNWhen (GXTG) Moves Investors should ListenNovember 23, 2024 | news.stocktradersdaily.comN(GXTG) Trading AdviceOctober 23, 2024 | news.stocktradersdaily.comN(GXTG) Long Term Investment AnalysisOctober 11, 2024 | news.stocktradersdaily.comN(GXTG) Investment Analysis and AdviceAugust 24, 2024 | news.stocktradersdaily.comNGlobal X Expands Roster of Thematic ETFs with Two Disruptive Tech Offerings and a Fund-of-Funds Thematic SolutionAugust 21, 2024 | br.advfn.comThe growing importance of CopperMay 21, 2024 | theglobeandmail.comGlobal X Thematic Growth ETF declares semi-annual distribution of $0.3824December 29, 2023 | msn.comGlobal X Nasdaq 100® Covered Call & Growth ETF declares $0.1441 dividendDecember 29, 2023 | msn.comGlobal X remains optimistic about 2024, but outlines 5 potential pitfallsDecember 15, 2023 | msn.comGlobal X Financials Covered Call & Growth ETF declares monthly distribution of $0.0756November 20, 2023 | msn.comGlobal X Health Care Covered Call & Growth ETF declares monthly distribution of $0.1025August 25, 2023 | seekingalpha.comMUSQ ETF TAKES CENTER STAGE AS ETC's NEWEST ENTERTAINMENT FUNDJuly 13, 2023 | technews.tmcnet.comGlobal X ETFs Launches the U.S. Cash Flow Kings 100 ETF (FLOW)July 12, 2023 | markets.businessinsider.comGlobal X Thematic Growth ETF declares semi-annual distribution of $0.1074June 30, 2023 | seekingalpha.comPolyester Chip (PET Chip) Market Size, Dynamics, Types, Applications, Top Key Vendors, Future Growth, Global Trends and Forecast till 2028September 13, 2022 | marketwatch.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCYTR, FTXH, FLN, and GXTG Company DescriptionsLadRx NASDAQ:CYTRLadRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded in 1985 and is headquartered in Los Angeles, CA.First Trust Latin America AlphaDEX Fund NASDAQ:FLN$18.95 +0.02 (+0.11%) As of 08/1/2025 03:56 PM EasternThe First Trust Latin America AlphaDEX Fund (FLN) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Latin America index. The fund tracks an index of Latin American firms screened based on a proprietary methodology, using various factors and weighted in tiers. FLN was launched on Apr 18, 2011 and is managed by First Trust.First Trust Nasdaq Pharmaceuticals ETF NASDAQ:FTXH$26.10 +0.34 (+1.34%) Closing price 08/1/2025 03:05 PM EasternExtended Trading$26.16 +0.06 (+0.21%) As of 08/1/2025 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.Global X Thematic Growth ETF NASDAQ:GXTG$26.08 -0.17 (-0.65%) As of 07/30/2025The Global X Thematic Growth ETF (GXTG) is an exchange-traded fund that is based on the Solactive Thematic Growth index. The fund is a passively managed fund-of-funds providing global equity exposure todisruptive-growth trends. Selectionisbased ona quantitativemethodologyemphasizingrealized sales growth. GXTG was launched on Oct 25, 2019 and is managed by Global X. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
